Parallax Volatility Advisers, L.P. Aldeyra Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.11 - $8.16 $70,442 - $94,076	11,529 Added 50.74%	34,252 $228,000
Q2 2023 Aug 14, 2023	BUY	$7.11 - $11.89 $161,560 - $270,176	22,723 New	22,723 $190,000
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $772 - $1,077	152 New	152 $1,000
Q2 2019 Aug 14, 2019	SELL	$6.0 - $9.0 $470,040 - $705,060	-78,340 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.14 - $9.85 $559,347 - $771,649	78,340 New	78,340 $707,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $278M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.